288 related articles for article (PubMed ID: 34164627)
21. Three molecular pathways model colorectal carcinogenesis in Lynch syndrome.
Ahadova A; Gallon R; Gebert J; Ballhausen A; Endris V; Kirchner M; Stenzinger A; Burn J; von Knebel Doeberitz M; Bläker H; Kloor M
Int J Cancer; 2018 Jul; 143(1):139-150. PubMed ID: 29424427
[TBL] [Abstract][Full Text] [Related]
22. Using CRISPR to understand how cancer mutations happen.
Rogers EH
Commun Biol; 2021 Jun; 4(1):807. PubMed ID: 34162994
[TBL] [Abstract][Full Text] [Related]
23. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
Zhang Y; Sastre D; Wang F
Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
[TBL] [Abstract][Full Text] [Related]
24. Validating the concept of mutational signatures with isogenic cell models.
Zou X; Owusu M; Harris R; Jackson SP; Loizou JI; Nik-Zainal S
Nat Commun; 2018 May; 9(1):1744. PubMed ID: 29717121
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional landscape of a RET
Hadoux J; Desterke C; Féraud O; Guibert M; De Rose RF; Opolon P; Divers D; Gobbo E; Griscelli F; Schlumberger M; Bennaceur-Griscelli A; Turhan AG
Stem Cell Res; 2018 Jan; 26():8-16. PubMed ID: 29197744
[TBL] [Abstract][Full Text] [Related]
26. DNA mismatch repair protects the genome from oxygen-induced replicative mutagenesis.
Lózsa R; Németh E; Gervai JZ; Márkus BG; Kollarics S; Gyüre Z; Tóth J; Simon F; Szüts D
Nucleic Acids Res; 2023 Nov; 51(20):11040-11055. PubMed ID: 37791890
[TBL] [Abstract][Full Text] [Related]
27. Experimental systems for the analysis of mutational signatures: no 'one-size-fits-all' solution.
Ivanov D; Hwang T; Sitko LK; Lee S; Gartner A
Biochem Soc Trans; 2023 Jun; 51(3):1307-1317. PubMed ID: 37283472
[TBL] [Abstract][Full Text] [Related]
28. Induction of mismatch repair deficiency, compromised DNA damage signaling and compound hypermutagenesis by a dietary mutagen in a cell-based model for Lynch syndrome.
Ijsselsteijn R; van Hees S; Drost M; Jansen JG; de Wind N
Carcinogenesis; 2022 Mar; 43(2):160-169. PubMed ID: 34919656
[TBL] [Abstract][Full Text] [Related]
29. Generation of a gene corrected human isogenic IBMS-iPSC-014-C from polycystic-kidney-disease induced pluripotent stem cell line using CRISPR/Cas9.
Liu CL; Huang CY; Chen HC; Lu HE; Hsieh PCH; Lee JJ
Stem Cell Res; 2020 May; 45():101784. PubMed ID: 32361310
[TBL] [Abstract][Full Text] [Related]
30. Modeling Human Severe Combined Immunodeficiency and Correction by CRISPR/Cas9-Enhanced Gene Targeting.
Chang CW; Lai YS; Westin E; Khodadadi-Jamayran A; Pawlik KM; Lamb LS; Goldman FD; Townes TM
Cell Rep; 2015 Sep; 12(10):1668-77. PubMed ID: 26321643
[TBL] [Abstract][Full Text] [Related]
31. Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas.
Clendenning M; Huang A; Jayasekara H; Lorans M; Preston S; O'Callaghan N; Pope BJ; Macrae FA; Winship IM; Milne RL; Giles GG; English DR; Hopper JL; Win AK; Jenkins MA; Southey MC; Rosty C; Buchanan DD;
Fam Cancer; 2018 Jan; 17(1):91-100. PubMed ID: 28616688
[TBL] [Abstract][Full Text] [Related]
32. Microsatellite instability and mutation of DNA mismatch repair genes in gliomas.
Leung SY; Chan TL; Chung LP; Chan AS; Fan YW; Hung KN; Kwong WK; Ho JW; Yuen ST
Am J Pathol; 1998 Oct; 153(4):1181-8. PubMed ID: 9777949
[TBL] [Abstract][Full Text] [Related]
33. Characterization of mismatch-repair/microsatellite instability-discordant endometrial cancers.
Riedinger CJ; Esnakula A; Haight PJ; Suarez AA; Chen W; Gillespie J; Villacres A; Chassen A; Cohn DE; Goodfellow PJ; Cosgrove CM
Cancer; 2024 Feb; 130(3):385-399. PubMed ID: 37751191
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of CRISPR/Cas9 site-specific function and validation of sgRNA sequence by a Cas9/sgRNA-assisted reverse PCR technique.
Zhang B; Zhou J; Li M; Wei Y; Wang J; Wang Y; Shi P; Li X; Huang Z; Tang H; Song Z
Anal Bioanal Chem; 2021 Apr; 413(9):2447-2456. PubMed ID: 33661348
[TBL] [Abstract][Full Text] [Related]
35. Efficient generation of targeted and controlled mutational events in porcine cells using nuclease-directed homologous recombination.
Butler JR; Santos RMN; Martens GR; Ladowski JM; Wang ZY; Li P; Tector M; Tector AJ
J Surg Res; 2017 May; 212():238-245. PubMed ID: 28550913
[TBL] [Abstract][Full Text] [Related]
36. CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities.
Ben Jehuda R; Eisen B; Shemer Y; Mekies LN; Szantai A; Reiter I; Cui H; Guan K; Haron-Khun S; Freimark D; Sperling SR; Gherghiceanu M; Arad M; Binah O
Heart Rhythm; 2018 Feb; 15(2):267-276. PubMed ID: 28917552
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
[TBL] [Abstract][Full Text] [Related]
38. Molecular analysis of cancer genomes in children with Lynch syndrome: Exploring causal associations.
Weijers DD; Hirsch S; Bakhuizen JJ; van Engelen N; Kester LA; Kranendonk MEG; Hiemcke-Jiwa LS; de Vos-Kerkhof E; Loeffen JLC; Autry RJ; Pajtler KW; Jäger N; Jongmans MCJ; Kuiper RP
Int J Cancer; 2024 Apr; 154(8):1455-1463. PubMed ID: 38175816
[TBL] [Abstract][Full Text] [Related]
39. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
Vermersch E; Jouve C; Hulot JS
Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
[TBL] [Abstract][Full Text] [Related]
40. The coding microsatellite mutation profile of PMS2-deficient colorectal cancer.
Bajwa-Ten Broeke SW; Ballhausen A; Ahadova A; Suerink M; Bohaumilitzky L; Seidler F; Morreau H; van Wezel T; Krzykalla J; Benner A; de Miranda NF; von Knebel Doeberitz M; Nielsen M; Kloor M
Exp Mol Pathol; 2021 Oct; 122():104668. PubMed ID: 34302852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
